{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:34:39Z","timestamp":1792028079189,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijantimicag.2024.107375","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T04:55:02Z","timestamp":1730436902000},"page":"107375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Isoniazid prophylaxis based on tuberculosis risk factors in living kidney transplantation recipients: A retrospective cohort study"],"prefix":"10.1016","volume":"64","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2024.107375_bib0001","series-title":"Global tuberculosis report 2023","year":"2023"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0002","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0003","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants","volume":"40","author":"Mu\u00f1oz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0004","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0005","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1111\/j.1600-6143.2009.02894.x","article-title":"Mycobacterium tuberculosis in solid organ transplant recipients","volume":"9","author":"Subramanian","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0006","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1093\/ndt\/gfr156","article-title":"Tuberculosis following kidney transplantation: clinical features and outcome. A French multicentre experience in the last 20 years","volume":"26","author":"Canet","year":"2011","journal-title":"Nephrol Dial Transplant: Off Publ Eur Dial Transpl Assoc \u2013 Eur Ren Assoc"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0007","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.00000712","article-title":"The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement","volume":"40","author":"Bumbacea","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0008","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish transplantation infection study group, GESITRA","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0009","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0010","doi-asserted-by":"crossref","first-page":"e13513","DOI":"10.1111\/ctr.13513","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American society of transplantation","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0011","series-title":"Guidelines on the management of latent tuberculosis infection","year":"2015"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0012","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1097\/TP.0000000000002014","article-title":"Tuberculosis recommendations for solid organ transplant recipients and donors","volume":"102","author":"Santoro-Lopes","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0013","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw694","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/bmb\/ldp039","article-title":"A 100 year update on diagnosis of tuberculosis infection","volume":"93","author":"Lalvani","year":"2010","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.kint.2016.01.034","article-title":"Tuberculosis and chronic kidney disease: an emerging global syndemic","volume":"90","author":"Romanowski","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0016","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1164\/rccm.201209-1621CI","article-title":"IFN-\u03b3 release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults","volume":"188","author":"Redelman-Sidi","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0017","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/TP.0b013e3182907073","article-title":"Contribution of interferon-\u03b3 release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation","volume":"95","author":"Hadaya","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0018","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1111\/ajt.12470","article-title":"Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area","volume":"13","author":"de Lemos","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0019","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/ndt\/gfp489","article-title":"Use of isoniazid chemoprophylaxis in renal transplant recipients","volume":"25","author":"Naqvi","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0020","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/jac\/dku562","article-title":"Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-\u03b3-releasing assay: an exploratory randomized controlled trial","volume":"70","author":"Kim","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107093","article-title":"IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: a single-centre retrospective study","volume":"63","author":"Zeng","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0022","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0000000000001329","article-title":"Twelve-week rifapentine plus isoniazid versus 9-month isoniazid for the treatment of latent tuberculosis in renal transplant candidates","volume":"101","author":"Simkins","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0023","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/TP.0000000000000133","article-title":"Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period","volume":"98","author":"Sidhu","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0024","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/tid.12436","article-title":"Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes","volume":"17","author":"Grim","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0025","doi-asserted-by":"crossref","first-page":"e13709","DOI":"10.1111\/tid.13709","article-title":"The efficacy of isoniazid prophylaxis in renal transplant recipients in a high tuberculosis burden country","volume":"23","author":"Dodani","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0026","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1186\/1471-2334-14-387","article-title":"The risk factors for tuberculosis in liver or kidney transplant recipients","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0027","first-page":"680","article-title":"Single center experience on characteristics and early diagnosis of pulmonary tuberculosis in renal transplant receipts (Chinese)","volume":"12","author":"Lin","year":"2013","journal-title":"J Clin Exp Med"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0028","doi-asserted-by":"crossref","first-page":"e36242","DOI":"10.2196\/36242","article-title":"Unbalanced risk of pulmonary tuberculosis in China at the subnational scale: spatiotemporal analysis","volume":"8","author":"Hu","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0029","doi-asserted-by":"crossref","first-page":"E169","DOI":"10.1111\/ctr.12077","article-title":"Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade","volume":"27","author":"Marques","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0030","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0031","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-3062.2005.00103.x","article-title":"Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy","volume":"7","author":"Vikrant","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0032","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199457110-00029","article-title":"A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients","volume":"57","author":"John","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0033","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11255-004-6251-6","article-title":"Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient","volume":"36","author":"Agarwal","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0034","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jinf.2020.06.070","article-title":"The usefulness of quantitative interferon-gamma releasing assay response for predicting active tuberculosis in kidney transplant recipients: a quasi-experimental study","volume":"81","author":"Kim","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ajt.12100","article-title":"Mycobacterium tuberculosis infections in solid organ transplantation","volume":"13","author":"Subramanian","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0036","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/ajt.15220","article-title":"Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: a retrospective cohort analysis","volume":"19","author":"Viana","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0037","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajt.2022.11.019","article-title":"Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020","volume":"23","author":"Katrak","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0038","doi-asserted-by":"crossref","first-page":"e13566","DOI":"10.1111\/tid.13566","article-title":"Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country","volume":"23","author":"Thitisuriyarax","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0039","doi-asserted-by":"crossref","first-page":"e12943","DOI":"10.1111\/tid.12943","article-title":"Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: a multicentric case-control study in a low-endemic area","volume":"20","author":"Gras","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107375_bib0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/tid.12501","article-title":"Epidemiology of tuberculosis after kidney transplantation in a developing country","volume":"18","author":"Meinerz","year":"2016","journal-title":"Transpl Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924002917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T11:02:47Z","timestamp":1734001367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924002917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0924857924002917"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107375","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoniazid prophylaxis based on tuberculosis risk factors in living kidney transplantation recipients: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107375"}}